{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T04:39:54Z","timestamp":1743136794257,"version":"3.40.3"},"publisher-location":"Basel","reference-count":141,"publisher":"Birkh\u00e4user Basel","isbn-type":[{"type":"print","value":"9783034871525"},{"type":"electronic","value":"9783034871501"}],"license":[{"start":{"date-parts":[[1993,1,1]],"date-time":"1993-01-01T00:00:00Z","timestamp":725846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1993,1,1]],"date-time":"1993-01-01T00:00:00Z","timestamp":725846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1993]]},"DOI":"10.1007\/978-3-0348-7150-1_6","type":"book-chapter","created":{"date-parts":[[2012,1,7]],"date-time":"2012-01-07T15:57:54Z","timestamp":1325951874000},"page":"151-189","source":"Crossref","is-referenced-by-count":0,"title":["Eradication by vaccination: the memorial to smallpox could be surrounded by others"],"prefix":"10.1007","author":[{"given":"Noel W.","family":"Preston","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"6_CR1","first-page":"9","volume":"23","author":"NW Preston","year":"1979","unstructured":"N. W. Preston: Some unsolved problems with vaccines. Prog. Drug Res. 23: 9\u201326 (1979).","journal-title":"Prog. Drug Res"},{"key":"6_CR2","first-page":"269","volume":"13","author":"World Health Organization","year":"1992","unstructured":"World Health Organization: International Task Force for disease eradication. Wld. Hlth. Forum 13: 269\u2013270 (1992).","journal-title":"Wld. Hlth. Forum"},{"key":"6_CR3","unstructured":"E. Ruiz-Tiben: Only four more years. World Health July-August: 9\u201310 (1992)."},{"key":"6_CR4","first-page":"299","volume":"15441545","author":"D Morley","year":"1989","unstructured":"D. Morley: Saving children\u2019s lives by vaccination. Br. Med. J. 299: 1544\u20131545 (1989).","journal-title":"Br. Med. J"},{"key":"6_CR5","first-page":"40","volume":"41","author":"Centers for Disease Control","year":"1992","unstructured":"Centers for Disease Control: Update - International Task Force for dis-ease eradication, 1990 and 1991. MMWR 41: 40\u201342 (1992).","journal-title":"MMWR"},{"key":"6_CR6","first-page":"335","volume":"13841387","author":"D Isaacs","year":"1990","unstructured":"D. Isaacs, M. Menser: Measles, mumps, rubella, and varicella. Lancet 335: 1384\u20131387 (1990).","journal-title":"Lancet"},{"key":"6_CR7","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/0140-6736(90)91138-Z","volume":"335","author":"A Eddleston","year":"1990","unstructured":"A. Eddleston: Hepatitis. Lancet 335: 1142\u20131145 (1990).","journal-title":"Hepatitis. Lancet"},{"key":"6_CR8","first-page":"527","volume-title":"Medical Microbiology","author":"JF Peutherer","year":"1992","unstructured":"J. F. Peutherer: Hepadnaviruses. In: D. Greenwood, R.C.B. Slack, J. F. Peutherer, eds. Medical Microbiology, 14th edn. Edinburgh: Churchill-Livingstone, pp. 527\u2013540 (1992)."},{"key":"6_CR9","unstructured":"Centers for Disease Control: Progress towards achieving the national 1990 objectives for immunization. MMWR 37: 613\u2013617 (1988)."},{"key":"6_CR10","doi-asserted-by":"crossref","unstructured":"Anonymous: Hepatitis A- a vaccine at last. Lancet 339: 1198\u20131199 (1992).","DOI":"10.1016\/0140-6736(92)91137-W"},{"key":"6_CR11","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1136\/bmj.306.6890.1464","volume":"306","author":"S Kingman","year":"1993","unstructured":"S. Kingman: Harvard lists top 10 medical advances. Br. Med. J. 306: 738 (1993).","journal-title":"Br. Med. J"},{"key":"6_CR12","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1056\/NEJM199208133270709","volume":"327","author":"WH Bancroft","year":"1992","unstructured":"W. H. Bancroft: Hepatitis A vaccine. N. Engl. J. Med. 327: 488\u2013490 (1992).","journal-title":"N. Engl. J. Med"},{"key":"6_CR13","unstructured":"World Health Organization: Control of viral hepatitis in Europe. Copenhagen: WHO EUR\/ICP\/OCD 016, pp. 2\u20134 (1992)."},{"key":"6_CR14","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/0140-6736(90)91200-T","volume":"335","author":"ER Moxon","year":"1990","unstructured":"E. R. Moxon, R. Rappuoli: Haemophilus influenzae infections and whooping cough. Lancet 335: 1324\u20131329 (1990).","journal-title":"Lancet"},{"key":"6_CR15","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/0140-6736(92)92719-V","volume":"340","author":"R Booy","year":"1992","unstructured":"R. Booy, E. R. Moxon, J. A. MacFarlane, R. T. Mayon-White, M. P. E. Slack: Efficacy of Haemophilus influenzae type b conjugate vaccine in Oxford region. Lancet 340: 847 (1992).","journal-title":"Lancet"},{"key":"6_CR16","unstructured":"Department of Health: Immunisation against infectious disease. London: HMSO, pp. 95\u201399(1992)."},{"key":"6_CR17","first-page":"335","volume":"12631266","author":"JHL Playfair","year":"1990","unstructured":"J. H. L. Playfair, J. M. Blackwell, H. R. P. Miller: Parasitic diseases. Lancet 335: 1263\u20131266 (1990).","journal-title":"Lancet"},{"key":"6_CR18","unstructured":"F. Y. Liew: Vaccination strategies of tropical diseases. Boca Raton, USA: CRC Press (1989)."},{"key":"6_CR19","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/0140-6736(93)90483-W","volume":"341","author":"MV Valero","year":"1993","unstructured":"M. V. Valero, L. R. Amador, C. Galindo, J. Figueroa, M. S. Bello, L. A. Murillo, et al.: Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in Colombia. Lancet 341: 705\u2013710 (1993).","journal-title":"Lancet"},{"key":"6_CR20","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/0140-6736(93)90494-2","volume":"341","author":"K Marsh","year":"1993","unstructured":"K. Marsh: Patarroyo\u2019s vaccine. Lancet 341: 729\u2013730 (1993).","journal-title":"Lancet"},{"key":"6_CR21","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/0140-6736(90)91013-Z","volume":"335","author":"MM Levine","year":"1990","unstructured":"M. M. Levine: Enteric infections. Lancet 335: 958\u2013961 (1990).","journal-title":"Lancet"},{"key":"6_CR22","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1128\/jcm.28.3.553-558.1990","volume":"28","author":"I Perez-Schael","year":"1990","unstructured":"I. Perez-Schael, M. Blanco, M. Vilar, D. Garcia, L. White, R. Gonzalez, et al.: Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants. J. Clin. Microbiol. 28: 553\u2013558 (1990).","journal-title":"J. Clin. Microbiol"},{"key":"6_CR23","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1136\/thx.43.5.345","volume":"43","author":"RT Mayon-White","year":"1988","unstructured":"R.T. Mayon-White: Pneumococcal vaccine. Thorax 43: 345\u2013348 (1988).","journal-title":"Thorax"},{"key":"6_CR24","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/0140-6736(90)90489-R","volume":"335","author":"F Shann","year":"1990","unstructured":"F. Shann: Pneumococcus and influenza. Lancet 335: 898\u2013901 (1990).","journal-title":"Lancet"},{"key":"6_CR25","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/S0140-6736(86)90690-2","volume":"1","author":"MR Lifely","year":"1986","unstructured":"M. R. Lifely, C. Moreno: Vaccine against meningococcal group B disease. Lancet 1: 214\u2013215 (1986).","journal-title":"Lancet"},{"key":"6_CR26","first-page":"5","volume":"1126","author":"MR Lifely","year":"1987","unstructured":"M. R. Lifely, C. Moreno, J. C. Lindon: An integrated molecular and immunological approach towards a meningococcal group B vaccine. Vaccine 5: 11\u201326 (1987).","journal-title":"Vaccine"},{"key":"6_CR27","first-page":"769","volume":"99","author":"AK Lehmann","year":"1991","unstructured":"A. K. Lehmann, A. Halstensen, A. Naess, S. E. Vollset, H. Sjursen, G. Bjune: Immunization against serogroup B meningococci. Acta Path. Microbiol. Immunol. Scand. 99: 769\u2013772 (1991).","journal-title":"Microbiol. Immunol. Scand"},{"key":"6_CR28","unstructured":"World Health Organization: Operational targets for EPI diseases. Copenhagen: WHO EUR\/ICP\/EPI031, pp. 3\u20134 (1993)."},{"key":"6_CR29","first-page":"1","volume-title":"Pathogenesis and immunity in pertussis","author":"NW Preston","year":"1988","unstructured":"N. W. Preston: Pertussis today. In: A. C. Wardlaw, R. Parton, eds. Pathogenesis and immunity in pertussis. Chichester: Wiley, pp. 1\u201318 (1988)."},{"key":"6_CR30","first-page":"81","volume":"939984","author":"JD Cherry","year":"1988","unstructured":"J. D. Cherry, P. A. Brunell, G. S. Golden, D. T. Karzon: Report of the Task Force on pertussis and pertussis immunization 1988. Pediatrics 81: 939\u2013984 (1988).","journal-title":"Pediatrics"},{"key":"6_CR31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1136\/bmj.305.6846.187-b","volume":"305","author":"E. Versi","year":"1992","unstructured":"E. Versi: \u201cGold standard\u201d is an appropriate term. Br. Med. J. 305; 187 (1992).","journal-title":"Br. Med. J."},{"key":"6_CR32","first-page":"6","volume":"7984","author":"NW Preston","year":"1983","unstructured":"N. W. Preston: The role of serology in the diagnosis of infection. Garyounis Med. J. 6: 79\u201384 (1983).","journal-title":"Garyounis Med. J"},{"key":"6_CR33","doi-asserted-by":"crossref","unstructured":"Anonymous: Pertussis - adults, infants, and herds. Lancet 339: 526\u2013527 (1992).","DOI":"10.1016\/0140-6736(92)90343-2"},{"key":"6_CR34","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/archpedi.1992.02160150067024","volume":"146","author":"P Camfleld","year":"1992","unstructured":"P. Camfleld: Brain damage from pertussis immunization. Am. J. Dis. Child. 146: 327\u2013331 (1992).","journal-title":"Am. J. Dis. Child"},{"key":"6_CR35","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0140-6736(90)90220-Y","volume":"335","author":"C.Bowie","year":"1990","unstructured":"C.Bowie: Lessons from the pertussis vaccine court trial. Lancet 335: 397\u2013399 (1990).","journal-title":"Lancet"},{"key":"6_CR36","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1001\/jama.1990.03440120101046","volume":"263","author":"J. D. Cherry","year":"1990","unstructured":"J. D. Cherry: \u2018Pertussis vaccine encephalopathy\u2019 - it is time to recognize it as the myth that it is. JAMA 263: 1679\u20131680 (1990).","journal-title":"JAMA"},{"key":"6_CR37","first-page":"287","volume":"87","author":"KR Wentz","year":"1991","unstructured":"K. R. Wentz, E. K. Marcuse: Diphtheria-tetanus-pertussis vaccine and serious neurologic illness. Pediatrics 87: 287\u2013297 (1991).","journal-title":"Pediatrics"},{"key":"6_CR38","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1136\/bmj.2.5359.724","volume":"11","author":"NW Preston","year":"1963","unstructured":"N. W. Preston: Type-specific immunity against whooping cough. Br. Med. J. 11: 724\u2013726 (1963).","journal-title":"Br. Med. J"},{"key":"6_CR39","unstructured":"E. Miller, J. E. Vurdien, J. M. White: The epidemiology of pertussis in England and Wales. Communicable Disease Report 2: R152\u2013R154"},{"key":"6_CR40","first-page":"R155","volume":"2","author":"NW Preston","year":"1992","unstructured":"N. W. Preston, E. J. Carter: Serotype specificity of vaccine-induced immunity to pertussis. Communicable Disease Report 2: R155\u2013R156 (1992).","journal-title":"Communicable Disease Report"},{"key":"6_CR41","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1084\/jem.171.1.63","volume":"777","author":"RD Shahin","year":"1990","unstructured":"R. D. Shahin, M.J. Brennan, Z. M. Li, B. D. Meade, C.R. Manclark: Characterization of the protective capacity and immunogenicity of the 69-KD outer membrane protein of Bordetella pertussis. J. Exp. Med. 777: 63\u201373 (1990).","journal-title":"J. Exp. Med"},{"key":"6_CR42","first-page":"363","volume":"95","author":"JH Fredriksen","year":"1987","unstructured":"J. H. Fredriksen, L. O. Froholm, U. Kjennerud: The specificity of antisera against Bordetella pertussis examined by bacterial agglutination. Acta Path. Microbiol. Immunol. Scand. 95: 363\u2013369 (1987).","journal-title":"Microbiol. Immunol. Scand"},{"key":"6_CR43","doi-asserted-by":"crossref","unstructured":"Ad hoc group for the study of pertussis vaccines: Placebo-controlled trial of two acellular pertussis vaccines in Sweden. Lancet i: 955\u2013960 (1988).","DOI":"10.1016\/S0140-6736(88)91778-3"},{"key":"6_CR44","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1017\/S095026880006708X","volume":"100","author":"AC Blaskett","year":"1988","unstructured":"A. C. Blaskett, J. C. Cox: Immunogenicity of specific Bordetella pertussis surface antigens in diphtheria-tetanus-pertussis (DTP) vaccines. Epidem. Infect. 100: 335\u2013344 (1988).","journal-title":"Epidem. Infect"},{"key":"6_CR45","first-page":"137","volume":"61","author":"NW Preston","year":"1985","unstructured":"N. W. Preston: Essential immunogens in human pertussis - the role of fimbriae. Develop. Biol. Standard. 61: 137\u2013141 (1985).","journal-title":"Develop. Biol. Standard"},{"key":"6_CR46","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/clinids\/13.6.1216","volume":"13","author":"A. Giammanco","year":"1991","unstructured":"A. Giammanco, A. Chiarini, T. Stroffolini, D. de Mattia, M. Chiaramonte, M. E. Moschen: Seroepidemiology of pertussis in Italy. Rev. Infect. Dis. 13: 1216\u20131220 (1991).","journal-title":"Rev. Infect. Dis."},{"key":"6_CR47","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1093\/ije\/18.4.959","volume":"18","author":"I Krantz","year":"1989","unstructured":"I. Krantz, J. Taranger, B. Trollfors: Estimating incidence of whooping cough overtime. Internat. J. Epidemiol. 18: 959\u2013963 (1989).","journal-title":"Internat. J. Epidemiol"},{"key":"6_CR48","doi-asserted-by":"crossref","unstructured":"E. K. Andersen: Serological studies on H. pertussis, H. parapertussis and H. bronchisepticus. Acta Path. Microbiol. Scand. 33: 202\u2013224 (1953).","DOI":"10.1111\/j.1699-0463.1953.tb01512.x"},{"key":"6_CR49","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1136\/bmj.303.6811.1204-b","volume":"303","author":"N. W. Preston","year":"1991","unstructured":"N. W. Preston: Assessing the response to pertussis vaccine. Br. Med. J. 303: 1204 (1991).","journal-title":"Br. Med. J."},{"key":"6_CR50","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0035-9203(79)90119-6","volume":"73","author":"MM Levine","year":"1979","unstructured":"M. M. Levine, D. R. Nalin, J. P. Craig, D. Hoover, E. J. Bergquist, D. Waterman, et al.: Immunity of cholera in man - relative role of antibacterial versus antitoxic immunity. Trans. R. Soc. Trop. Med. Hyg. 73: 3\u20139 (1979).","journal-title":"Trans. R. Soc. Trop. Med. Hyg"},{"key":"6_CR51","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1017\/S0950268800050913","volume":"110","author":"NW Preston","year":"1993","unstructured":"N. W. Preston: Corresponding type-specificity of vibriocidal and agglutinating activities of Vibrio cholerae antisera - relevance to vaccine immunogenicity. Epidemiol. Infect. 110: 489\u2013497 (1993).","journal-title":"Epidemiol. Infect"},{"key":"6_CR52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/infdis\/121.Supplement.S1","volume":"121","author":"W. H. Mosley","year":"1970","unstructured":"W. H. Mosley, W. E. Woodward, K. M. A. Aziz, A. S. M. M. Rahman, A. K. M. A. Chowdhury, A. Ahmed: The 1968\u20131969 cholera-vaccine field trial in rural East Pakistan. J. Infect. Dis. 121 Suppl: S 1\u2013S9 (1970).","journal-title":"J. Infect. Dis."},{"key":"6_CR53","first-page":"337","volume":"10971098","author":"IK Wachsmuth","year":"1991","unstructured":"I. K. Wachsmuth, C. A. Bopp, P. I. Fields, C. Carrillo: Difference between toxigenic Vibrio cholerae 01 from South America and US gulf coast. Lancet 337: 1097\u20131098 (1991).","journal-title":"Lancet"},{"key":"6_CR54","first-page":"23","volume":"918","author":"S Kabir","year":"1987","unstructured":"S. Kabir: Preparation and immunogenicity of a bivalent cell-surface protein-polysaccharide conjugate of Vibrio cholerae. J. Med. Microbiol. 23: 9\u201318 (1987).","journal-title":"J. Med. Microbiol"},{"key":"6_CR55","unstructured":"S. Rahman (ed): Proceedings of the Conference on Experimental Cholera Vaccines, Dacca, Bangladesh, 6\u20138 April 1981. Dacca: International Centre for Diarrhoeal Disease Research, Special Publication 15, pp. 112\u2013113 (1981)."},{"key":"6_CR56","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/0140-6736(93)90480-5","volume":"341","author":"T Ramamurthy","year":"1993","unstructured":"T. Ramamurthy, S. Garg, R. Sharma, S. K. Bhattacharya, G. B. Nair, T. Shimada, et al.: Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India. Lancet 341: 703\u2013704 (1993).","journal-title":"Lancet"},{"key":"6_CR57","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/0140-6736(93)90481-U","volume":"341","author":"MJ Albert","year":"1993","unstructured":"M. J. Albert, A. K. Siddique, M. S. Islam, A. S. G. Faruque, M. Ansaruzzaman, S. M. Faruque, et al.: Large outbreak of clinical cholera due to Vibrio cholerae non-01 in Bangladesh. Lancet 341: 704 (1993).","journal-title":"Lancet"},{"key":"6_CR58","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1016\/0140-6736(91)92755-Q","volume":"338","author":"NW Preston","year":"1991","unstructured":"N. W. Preston: Oral typhoid vaccine Ty21 a. Lancet 338: 1456 (1991).","journal-title":"Lancet"},{"key":"6_CR59","doi-asserted-by":"crossref","unstructured":"Anonymous: Typhoid vaccination - weighing the options. Lancet 340: 341\u2013342 (1992).","DOI":"10.1016\/0140-6736(92)91408-Z"},{"key":"6_CR60","doi-asserted-by":"crossref","unstructured":"Anonymous: Typhoid vaccines - which one to choose? Drug Ther. Bull. 31: 9\u201310 (1993).","DOI":"10.1136\/dtb.31.3.9"},{"key":"6_CR61","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1056\/NEJM198710293171801","volume":"317","author":"IL Acharya","year":"1987","unstructured":"I. L. Acharya, C.U. Lowe, R. Thapa, V. L. Gurubacharya, M. B. Shrestha, M. Cadoz, et al.: Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. N. Engl. J. Med. 317: 1101\u20131104 (1987).","journal-title":"N. Engl. J. Med"},{"key":"6_CR62","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/S0140-6736(87)91316-X","volume":"11","author":"KP Klugman","year":"1987","unstructured":"K. P. Klugman, I. T. Gilbertson, H. J. Koornhof, J. B. Robbins, R. Schneerson, D. Schulz, et al.: Protective activity of Vi capsular polysaccharide vaccine against typhoid fever. Lancet 11: 1165\u20131169 (1987).","journal-title":"Lancet"},{"key":"6_CR63","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1093\/infdis\/154.2.342","volume":"154","author":"CO Tacket","year":"1986","unstructured":"C. O. Tacket, C. Ferreccio, J. B. Robbins, C-M. Tsai, D. Schulz, M. Cadoz, et al.: Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccines. J. Infect. Dis. 154: 342\u2013345 (1986).","journal-title":"J. Infect. Dis"},{"key":"6_CR64","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/infdis\/159.4.766","volume":"159","author":"C. Ferreccio","year":"1989","unstructured":"C. Ferreccio, M. M. Levine, H. Rodriguez, R. Contreras, Chilean Typhoid Committee: Comparative efficacy of two, three, or four doses of Ty21a live oral typhoid vaccine in enteric-coated capsules. J. Infect. Dis. 159: 766\u2013769 (1989).","journal-title":"J. Infect. Dis."},{"key":"6_CR65","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/0140-6736(92)90378-G","volume":"339","author":"NW Preston","year":"1992","unstructured":"N. W. Preston: Typhoid vaccine and laboratory indicators of clinical protection. Lancet 339: 555 (1992).","journal-title":"Lancet"},{"key":"6_CR66","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/0140-6736(90)90945-2","volume":"335","author":"AJ Beale","year":"1990","unstructured":"A. J. Beale: Polio vaccines - time for a change in immunisation policy. Lancet 335: 839\u2013842 (1990).","journal-title":"Lancet"},{"key":"6_CR67","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1093\/infdis\/166.4.935","volume":"166","author":"D Murdin","year":"1992","unstructured":"D.. Murdin, J. Thipphawong: Poliovirus vaccination schedules and reversion to virulence. J. Infect. Dis. 166: 935\u2013936 (1992).","journal-title":"J. Infect. Dis"},{"key":"6_CR68","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1001\/jama.1991.03470190072032","volume":"266","author":"PW Kelley","year":"1991","unstructured":"P. W. Kelley, B. P. Petruccelli, P. Stehr-Green, R. L. Erickson, C. J. Mason: The susceptibility of young adult Americans to vaccine-preventable infections. JAMA 266: 2724\u20132729 (1991).","journal-title":"Jama"},{"key":"6_CR69","first-page":"93","volume":"70","author":"PW Kok","year":"1992","unstructured":"P. W. Kok, J. Leeuwenburg, P. Tukei, A. L. van Wezel, J. G. Kapsenberg, G. van Steenis, et al.: Serological and virological assessment of oral and inactivated poliovirus vaccines in a rural population in Kenya. Bull. Wld. Hlth. Org. 70: 93\u2013103 (1992).","journal-title":"Bull. Wld. Hlth. Org"},{"key":"6_CR70","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0033-3506(05)80341-5","volume":"104","author":"P. Hatton","year":"1990","unstructured":"P. Hatton: The use of the screening technique as a method of rapidly estimating vaccine efficacy. Publ. Hlth. 104:21\u201325 (1990).","journal-title":"Publ. Hlth."},{"key":"6_CR71","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/tropej\/30.3.184","volume":"30","author":"C. M. Roberts","year":"1984","unstructured":"C. M. Roberts: The short-term effects of a measles vaccination programme on a rural Nigerian community. J. Trop. Pediatr. 30: 184\u2013188 (1984).","journal-title":"J. Trop. Pediatr."},{"key":"6_CR72","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/0140-6736(93)90454-O","volume":"341","author":"NW Preston","year":"1993","unstructured":"N. W. Preston: Measles control in young infants. Lancet 341: 688\u2013689 (1993).","journal-title":"Lancet"},{"key":"6_CR73","first-page":"92","volume":"21","author":"O Lindqvist","year":"1987","unstructured":"O. Lindqvist, A. Mark, O. Strannegard: Antibody responses following immunization with combined measles-mumps-rubella (MMR) vaccine of 12-month-old-infants in Kuwait. J. Kuwait.Med. Assoc. 21: 92\u201396 (1987).","journal-title":"J. Kuwait.Med. Assoc"},{"key":"6_CR74","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/00006454-199004000-00008","volume":"9","author":"D Schoub","year":"1990","unstructured":"D. Schoub, S. Johnson, J. M. McAnerney, L. A. Wagstaff, W. Matsie, S. G. Reinach, et al.: Measles mumps and rubella immunization at nine months in a developing country. Pediatr. Infect. Dis. J. 9: 263\u2013267 (1990).","journal-title":"Pediatr. Infect. Dis. J"},{"key":"6_CR75","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1542\/peds.74.1.90","volume":"74","author":"MD Murphy","year":"1984","unstructured":"M. D. Murphy, P. A. Brunell, A. W. Lievens, Z. M. Shehab: Effect of early immunization on antibody response to reimunization with measles vaccine as demonstrated by enzyme-linked immunosorbent assay (ELISA). Pediatrics 74: 90\u201393 (1984).","journal-title":"Pediatrics"},{"key":"6_CR76","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/0140-6736(90)90773-X","volume":"335","author":"R Berger","year":"1990","unstructured":"R. Berger, M. Just, R. Gl\u00fcck, M. Grassi, A. Wegmann: Measles vaccination in early infancy. Lancet 335: 540 (1990).","journal-title":"Lancet"},{"key":"6_CR77","doi-asserted-by":"crossref","unstructured":"World Health Organization EPI: Measles immunisation before the age of nine months? Lancet ii: 1356\u20131357 (1988).","DOI":"10.1016\/S0140-6736(88)90882-3"},{"key":"6_CR78","first-page":"136","volume":"21","author":"S Portoian-Shuhaiber","year":"1987","unstructured":"S. Portoian-Shuhaiber: Mumps and rubella, or measles, mumps and rubella vaccination in children. J. Kuwait Med. Assoc. 21: 136\u2013137 (1987).","journal-title":"J. Kuwait Med. Assoc"},{"key":"6_CR79","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1136\/bmj.306.6872.222","volume":"306","author":"KM Citron","year":"1993","unstructured":"K. M. Citron: BCG vaccination against tuberculosis - international perspectives. Br. Med. J. 306: 222\u2013223 (1993).","journal-title":"Br. Med. J"},{"key":"6_CR80","first-page":"335","volume":"10161020","author":"PEM Fine","year":"1990","unstructured":"P. E. M. Fine, L. C. Rodrigues: Mycobacterial diseases. Lancet 335: 1016\u20131020 (1990).","journal-title":"Lancet"},{"key":"6_CR81","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0041-3879(86)90016-4","volume":"67","author":"O Tidjani","year":"1986","unstructured":"O. Tidjani, A. Amedome, H. G. ten Dam: The protective effect of BCG vaccination of the newborn against childhood tuberculosis in an African community. Tubercle 67: 269\u2013281 (1986).","journal-title":"Tubercle"},{"key":"6_CR82","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0041-3879(67)80024-2","volume":"48","author":"P. d\u2019A. Hart","year":"1967","unstructured":"P. d\u2019A. Hart, I. Sutherland, J. Thomas: The immunity conferred by effective BCG and vole bacillus vaccines, in relation to individual variations in induced tuberculin sensitivity and to technical variations in the vaccines. Tubercle 48: 201\u2013210 (1967).","journal-title":"Tubercle"},{"key":"6_CR83","doi-asserted-by":"crossref","unstructured":"Hayward: Re-emergence of tuberculosis. Br. Med. J. 306: 514\u2013515 (1993).","DOI":"10.1136\/bmj.306.6876.514-b"},{"key":"6_CR84","first-page":"227","volume":"22","author":"VM C\u00e1rdenas-Ayala","year":"1988","unstructured":"V. M. C\u00e1rdenas-Ayala, H. Vilchis-Lic\u00f3n, H. C. Stetler, L. Cabrera-Coello, J. S. Koopman, J. L. Valdespino-G\u00f3mez, et al.: Risk factors for the persistence of wild poliovirus transmission in Sinaloa, Mexico, 1984\u20131986. Pan Am. Hlth. Org. Bull. 22: 227\u2013239 (1988).","journal-title":"Am. Hlth. Org. Bull"},{"key":"6_CR85","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1017\/S0022172400055133","volume":"76","author":"JWG Smith","year":"1976","unstructured":"J. W. G. Smith, J. A. Lee, W. B. Fletcher, C. A. Morris, D. A. Parker, R. Yetts, et al.: The reponse to oral poliovaccine in persons aged 16\u201318 years. J. Hyg. Camb. 76: 235\u2013247 (1976).","journal-title":"J. Hyg. Camb"},{"key":"6_CR86","first-page":"340","volume":"689694","author":"C Suharyono","year":"1992","unstructured":"Suharyono, C. Simanjuntak, N. Witham, N. Punjabi, D. G. Heppner, G. Losonsky, et al.: Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children. Lancet 340: 689\u2013694 (1992).","journal-title":"Lancet"},{"key":"6_CR87","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1128\/iai.60.9.3916-3917.1992","volume":"60","author":"SJ Cryz","year":"1992","unstructured":"S. J. Cryz, M.M. Levine, G. Losonsky, J. B. Kaper, B. Althaus: Safety and immunogenicity of a booster dose of Vibrio cholerae CVD 103-HgR live oral cholera vaccine in Swiss adults. Infect. Immun. 60: 3916\u20133917 (1992).","journal-title":"Infect. Immun"},{"key":"6_CR88","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/infdis\/155.1.79","volume":"155","author":"JD Clemens","year":"1987","unstructured":"J. D. Clemens, B. F. Stanton, J. Chakraborty, D. A. Sack, M. R. Khan, S. Huda, et al.: B subunit-whole cell and whole cell-only oral vaccines against cholera. J. Infect. Dis. 155: 79\u201385 (1987).","journal-title":"J. Infect. Dis"},{"key":"6_CR89","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/0140-6736(90)90080-O","volume":"335","author":"JD Clemens","year":"1990","unstructured":"J. D. Clemens, D. A. Sack, J. R. Harris, F. van Loon, J. Chakraborty, F. Ahmed, et al.: Field trial of oral cholera vaccines in Bangladesh. Lancet 335: 270\u2013273 (1990).","journal-title":"Lancet"},{"key":"6_CR90","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1093\/infdis\/163.6.1235","volume":"163","author":"JD Clemens","year":"1991","unstructured":"J. D. Clemens, F. van Loon, D. A. Sack, J. Chakraborty, M. R. Rao, F. Ahmed, et al.: Field trial of oral cholera vaccines in Bangladesh - serum vibriocidal and antitoxic antibodies as markers of the risk of cholera. J. Infect. Dis. 163: 1235\u20131242 (1991).","journal-title":"J. Infect. Dis"},{"key":"6_CR91","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/0140-6736(92)92284-M","volume":"340","author":"C Sesardic","year":"1992","unstructured":"Sesardic, M. J. Corbel: Testing for neutralising potential of serum antibodies to tetanus and diphtheria toxin. Lancet 340: 737\u2013738 (1992).","journal-title":"Lancet"},{"key":"6_CR92","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/00006454-198804000-00005","volume":"7","author":"S Isomura","year":"1988","unstructured":"S. Isomura: Efficacy and safety of acellular pertussis vaccine in Aichi Prefecture, Japan. Pediatr. Infect. Dis. J. 7: 258\u2013262 (1988).","journal-title":"Japan. Pediatr. Infect. Dis. J"},{"key":"6_CR93","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1093\/infdis\/160.5.832","volume":"160","author":"KM Edwards","year":"1989","unstructured":"K. M. Edwards, R. B. Bradley, M. D. Decker, P. S. Palmer, J. van Savage, J. C. Taylor, et al.: Evaluation of a new highly purified pertussis vaccine in infants and children. J. Infect. Dis. 160: 832\u2013837 (1989).","journal-title":"J. Infect. Dis"},{"key":"6_CR94","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/0264-410X(92)90083-V","volume":"10","author":"AC Wardlaw","year":"1992","unstructured":"A. C. Wardlaw: Multiple discontinuity as a remarkable feature of the development of acellular pertussis vaccines. Vaccine 10: 643\u2013651 (1992).","journal-title":"Vaccine"},{"key":"6_CR95","first-page":"267","volume":"27882790","author":"D Shapiro","year":"1992","unstructured":"D. Shapiro: Pertussis vaccines - seeking a better mousetrap. JAMA 267: 2788\u20132790 (1992).","journal-title":"Jama"},{"key":"6_CR96","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/0140-6736(90)91165-7","volume":"335","author":"N. W. Preston","year":"1990","unstructured":"N. W. Preston: Pertussis vaccine. Lancet 335:1162 (1990). V. I. Levenson, T. P. Egorova, Z. P. Belkin, V. G. Fedosova, J. L. Subbo- tina, E. Z. Rukhadze: Protective ribosomal preparation from Shigella sonnei as a parenteral candidate vaccine. Infect. Immun. 59: 3610\u20133618 (1991).","journal-title":"Lancet"},{"key":"6_CR97","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1128\/iai.59.10.3610-3618.1991","volume":"59","author":"V. I. Levenson","year":"1991","unstructured":"V. I. Levenson, T. P. Egorova, Z. P. Belkin, V. G. Fedosova, J. L. Subbo- tina, E. Z. Rukhadze,: Protective ribosomal preparation from Shigella sonnei as a parenteral candidate vaccine. Infect. Immun. 59: 3610\u20133618 (1991).","journal-title":"Infect. Immun."},{"key":"6_CR98","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/0140-6736(90)92256-H","volume":"336","author":"NW Preston","year":"1990","unstructured":"N. W. Preston: Antigens that modern vaccines must contain. Lancet 336: 756\u2013757 (1990).","journal-title":"Lancet"},{"key":"6_CR99","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/0140-6736(90)90360-H","volume":"335","author":"Brown","year":"1990","unstructured":"Brown: From Jenner to genes - the new vaccines. Lancet 335: 587\u2013590 (1990).","journal-title":"Lancet"},{"key":"6_CR100","doi-asserted-by":"crossref","unstructured":"J. C. Kelsey: The AP Syndrome. Br. Med. J. IV: 104, 360 (1973).","DOI":"10.2307\/3958323"},{"key":"6_CR101","unstructured":"A. Hanrahan, J. Waters: Adverse local reactions to fourth and fifth doses of DPT vaccine - Alberta. Canada Diseases Weekly Report 14: 45\u201347"},{"key":"6_CR102","first-page":"641","volume":"145","author":"D. W. Scheifele","year":"1991","unstructured":"D. W. Scheifele, W. Meekison, M.Grace, L. Barreto, A. O. Carter, L. Mitchell: Adverse reactions to the preschool (fifth) dose of adsorbed diphtheria-pertussis-tetanus vaccine in Canadian children. Canad. Med. Assoc. J. 145: 641\u2013647 (1991).","journal-title":"Canad. Med. Assoc. J."},{"key":"6_CR103","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1136\/adc.66.12.1408","volume":"66","author":"P. L. Verschoor","year":"1991","unstructured":"P. L. Verschoor, J. T. Wilschut, G. A. de Jonge, P. J. Kostense: Frequent symptoms after DTPP vaccinations. Arch. Dis. Child. 66: 1408\u20131412 (1991).","journal-title":"Arch. Dis. Child."},{"key":"6_CR104","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1097\/00006454-198708000-00005","volume":"6","author":"MM Ipp","year":"1987","unstructured":"M. M. Ipp, R. Gold, S. Greenberg, M. Goldbach, B. B. Kupfert, D. D. Lloyd, et al.: Acetaminophen prophylaxis of adverse reactions following vaccination of infants with diphtheria-pertussis-tetanus toxoids-polio vaccine. Pediatr. Infect. Dis. J. 6: 721\u2013725 (1987).","journal-title":"Pediatr. Infect. Dis. J"},{"key":"6_CR105","doi-asserted-by":"crossref","unstructured":"Anonymous: Prophylactic paracetamol with childhood immunisation? Drug Ther. Bull. 28: 73\u201374 (1990).","DOI":"10.1136\/dtb.28.19.73"},{"key":"6_CR106","doi-asserted-by":"crossref","unstructured":"L. J. Baraff, C. R. Manclark, J. D. Cherry, P. Christenson, S. M. Marcy: Analyses of adverse reactions to diphtheria and tetanus toxoids and pertussis vaccine by vaccine lot, endotoxin content, pertussis vaccine potency and percentage of mouse weight gain. Pediatr. Infect. Dis. J. 8: 502\u2013507","DOI":"10.1097\/00006454-198908000-00006"},{"key":"6_CR107","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/archpedi.1990.02150250047029","volume":"144","author":"CM Morgan","year":"1990","unstructured":"C. M. Morgan, D. A. Blumberg, J. D. Cherry, K. S. Reisinger, M. M. Blatter, J. L. Blumer, et al.: Comparison of acellular and whole-cell pertussis- component DTP vaccines. Am. J. Dis. Child. 144: 41\u201345 (1990).","journal-title":"Am. J. Dis. Child"},{"key":"6_CR108","unstructured":"S. A. Plotkin, E. A. Mortimer: Vaccines. London: Saunders, pp. 612\u2013621 (1988)."},{"key":"6_CR109","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1542\/peds.82.2.264","volume":"82","author":"MH Smith","year":"1988","unstructured":"M. H. Smith: National Childhood Vaccine Injury Compensation Act. Pediatrics 82: 264\u2013269 (1988).","journal-title":"Pediatrics"},{"key":"6_CR110","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1348-0421.1990.tb03167.x","volume":"34","author":"T Nakayama","year":"1990","unstructured":"T. Nakayama, T. Urano, M. Osano, M. Nakagawa, N. Maehara, K. Sasaki, et al.: Evaluation of live trivalent vaccine of measles AIK-C strain, mumps Hoshino strain and rubella Takahashi strain, by virus-specific interferon-production and antibody response. Microbiol. Immunol. 34: 497\u2013508 (1990).","journal-title":"Microbiol. Immunol"},{"key":"6_CR111","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/0140-6736(92)92322-7","volume":"340","author":"A Colville","year":"1992","unstructured":"A. Colville, S. Pugh: Mumps meningitis and measles, mumps, and rubella vaccine. Lancet 340: 786 (1992).","journal-title":"Lancet"},{"key":"6_CR112","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/0140-6736(92)92873-E","volume":"340","author":"T Forsey","year":"1992","unstructured":"T. Forsey, M. L. Bentley, P. D. Minor, N. Begg: Mumps vaccines and meningitis. Lancet 340: 980 (1992).","journal-title":"Lancet"},{"key":"6_CR113","first-page":"184","volume":"7","author":"JP Grant","year":"1986","unstructured":"J. P. Grant: Getting vaccination to the people. Wld. Hlth. Forum 7: 184 (1986).","journal-title":"Wld. Hlth. Forum"},{"key":"6_CR114","unstructured":"World Health Organization: Expanded Programme on Immunization - programme acceleration. Wkly Epidemiol. Record 62: 173\u2013175 (1987)."},{"key":"6_CR115","unstructured":"T. Thomas: Why child vaccines may be a shot in the dark. The Independent newspaper, No. 1968, p. 12(1993)."},{"key":"6_CR116","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1136\/bmj.303.6796.248","volume":"303","author":"NW Preston","year":"1991","unstructured":"N. W. Preston: Accelerated immunisation with diphtheria-tetanus-pertus- sis vaccine. Br. Med. J. 303: 248 (1991).","journal-title":"Br. Med. J"},{"key":"6_CR117","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1542\/peds.73.1.11","volume":"73","author":"LJ Baraff","year":"1984","unstructured":"L. J. Baraff, R. D. Leake, D. G. Burstyn, T. Payne, C. L. Cody, C. R. Manclark, et al.: Immunologic response to early and routine DTP immunization in infants. Pediatrics 73: 11\u201342 (1984).","journal-title":"Pediatrics"},{"key":"6_CR118","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0140-6736(92)90336-2","volume":"339","author":"R. Booy","year":"1992","unstructured":"R. Booy, S. J. M. Aitken, S. Taylor, G. Tudor-Williams, J. A. MacFarlane, E.R. Moxon: Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age. Lancet 339: 507\u2013510 (1992).","journal-title":"Lancet"},{"key":"6_CR119","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/infdis\/161.3.487","volume":"161","author":"J Savage","year":"1990","unstructured":"J. van Savage, M. D. Decker, K. M. Edwards, S. H. Sell, D. T. Karzon: Natural history of pertussis antibody in the infant and effect on vaccine response. J. Infect. Dis. 161: 487\u2013492 (1990).","journal-title":"J. Infect. Dis"},{"key":"6_CR120","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/0140-6736(92)90378-G","volume":"339","author":"N. W. Preston","year":"1992","unstructured":"N. W. Preston: Diphtheria, pertussis, and tetanus vaccination. Lancet 339: 1356 (1992).","journal-title":"Lancet"},{"key":"6_CR121","first-page":"103","volume":"41","author":"D Alford","year":"1992","unstructured":"D. Alford, J. Kelly, T. J. Halpin, L. Nickey, R. Crider, J. Arrandondo, et al.: Retrospective assessment of vaccination coverage among school-aged children. MMWR 41: 103\u2013107 (1992).","journal-title":"Mmwr"},{"key":"6_CR122","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1542\/peds.85.3.294","volume":"85","author":"SS Long","year":"1990","unstructured":"S. S. Long, A. Deforest, D. G. Smith, C. Lazaro, S. G. F. Wassilak: Longitudinal study of adverse reactions following diphtheria-tetanus-pertussis vaccine in infancy. Pediatrics 85: 294\u2013302 (1990).","journal-title":"Pediatrics"},{"key":"6_CR123","first-page":"853","volume":"64","author":"D Dexiang","year":"1986","unstructured":"D. De-xiang, H. Xi-min, L. Wan-jun, L. Jin-shen, J. Yu-cai, T. Shun-ge, et al.: Immunization of neonates with trivalent oral poliomyelitis vaccine (Sabin). Bull. Wld. Hlth. Org. 64: 853\u2013860 (1986).","journal-title":"Bull. Wld. Hlth. Org"},{"key":"6_CR124","first-page":"85","volume":"70","author":"LY Weckx","year":"1992","unstructured":"L. Y. Weckx, B. J. Schmidt, A. A. Herrmann, C. H. Miyasaki, N. F. Novo: Early immunization of neonates with trivalent oral poliovirus vaccine. Bull. Wld. Hlth. Org. 70: 85 - 91 (1992).","journal-title":"Bull. Wld. Hlth. Org"},{"key":"6_CR125","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/BF01962073","volume":"11","author":"G Hess","year":"1992","unstructured":"G. Hess, V. Hingst, J. Cseke, H. L. Bock, R. Clemens: Influence of vaccination schedules and host factors on antibody response following hepatitis B vaccination. Eur. J. Clin. Microbiol. Infect. Dis. 11: 334\u2013340 (1992).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis"},{"key":"6_CR126","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/0140-6736(93)92537-4","volume":"341","author":"P Poore","year":"1993","unstructured":"P. Poore, F. Cutts, J. Seaman: Universal Childhood Immunisation - is it sustainable Lancet 341: 58 (1993).","journal-title":"Lancet"},{"key":"6_CR127","first-page":"685","volume":"341","author":"J Beale","year":"1993","unstructured":"J. Beale: Obituary - Albert Sabin. Lancet 341: 685 (1993).","journal-title":"Lancet"},{"key":"6_CR128","doi-asserted-by":"crossref","unstructured":"R. D. Ebong: An evaluation of immunization coverage of Nigerian army depot. J. Roy. Soc. Hlth. February: 3\u20136 (1992).","DOI":"10.1177\/146642409211200101"},{"key":"6_CR129","first-page":"283","volume":"142","author":"T Lewis","year":"1988","unstructured":"T. Lewis, L. M. Osborn, K. Lewis, J. Brockert, J. Jacobsen, J. D. Cherry: Influence of parental knowledge and opinions on 12-month diphtheria, tetanus, and pertussis vaccination rates. Am. J. Dis. Child. 142: 283\u2013286 (1988).","journal-title":"Am. J. Dis. Child"},{"key":"6_CR130","first-page":"277","volume":"105","author":"P Stehr-Green","year":"1992","unstructured":"P. Stehr-Green, C. Briasco, M. Baker, P. Trotter: How well are we protecting our children? - an immunisation coverage survey in Hawke\u2019s Bay. NZ. Med. J. 105: 277\u2013279 (1992).","journal-title":"Med. J"},{"key":"6_CR131","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/her\/7.3.341","volume":"7","author":"P Bennett","year":"1992","unstructured":"P. Bennett, C. Smith: Parents attitudinal and social influences on childhood vaccination. Hlth. Education Res. 7: 341\u2013348 (1992).","journal-title":"Hlth. Education Res"},{"key":"6_CR132","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1136\/bmj.302.6767.31","volume":"302","author":"DJ Riley","year":"1991","unstructured":"D. J. Riley, M. Z. Mughal, J. Roland: Immunisation state of young children admitted to hospital and effectiveness of a ward based opportunistic immunisation policy. Br. Med. J. 302: 31\u201333 (1991).","journal-title":"Br. Med. J"},{"key":"6_CR133","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1097\/00006454-199008000-00009","volume":"9","author":"MRZ Capeding","year":"1990","unstructured":"M. R. Z. Capeding, J. A. Lazaro, Y. Y. Kaneko: Pre-discharge immunization among hospitalized Filipino children. Pediatr. Infect. Dis. J. 9: 570\u2013573 (1990).","journal-title":"Pediatr. Infect. Dis. J"},{"key":"6_CR134","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1136\/bmj.304.6830.816","volume":"304","author":"LD Ritchie","year":"1992","unstructured":"L. D. Ritchie, A. F. Bisset, D. Russell, V. Leslie, I. Thomson: Primary and preschool immunisation in Grampian - progress and the 1990 contract. Br. Med. J. 304: 816\u2013819 (1992).","journal-title":"Br. Med. J"},{"key":"6_CR135","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1001\/archpedi.1986.02140190027016","volume":"140","author":"JD Cherry","year":"1986","unstructured":"J. D. Cherry: The pertussis epidemic in Oklahoma - a warning for the future. Am. J. Dis. Child. 140: 417\u2013418 (1986).","journal-title":"Am. J. Dis. Child"},{"key":"6_CR136","unstructured":"J. B. Robbins, J. C. Hill, J. C. Sadoff (eds): Bacterial vaccines. In: L. Weinstein, B. N. Fields, Seminars in Infectious Disease, vol. I V. New York: Thieme-Stratton (1982)."},{"key":"6_CR137","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/0140-6736(90)92645-X","volume":"335","author":"GC Schild","year":"1990","unstructured":"G. C. Schild, P. D. Minor: Human immunodeficiency virus and AIDS - challenges and progress. Lancet 335: 1081\u20131084 (1990).","journal-title":"Lancet"},{"issue":"4","key":"6_CR138","first-page":"14","volume":"72","author":"N. W. Preston","year":"1992","unstructured":"N. W. Preston: Self-control crucial to health promotion. Hospital Doctor C 72(4): 14(1992).","journal-title":"Hospital Doctor C"},{"key":"6_CR139","unstructured":"World Health Organization: \u201cAIDS: a community commitment\u201d is the theme of World AIDS Day 1992. Wld. Hlth. Forum 13:270 (1992)."},{"key":"6_CR140","unstructured":"World Health Organization: New AIDS strategy. Wld. Hlth. Forum 13: 92 (1992)."},{"key":"6_CR141","doi-asserted-by":"crossref","unstructured":"Anonymous: Switzerland (WHO) - resignation of Dr Jonathan Mann. Lancet 335: 716 (1990).","DOI":"10.1016\/0140-6736(90)90818-P"}],"container-title":["Progress in Drug Research \/ Fortschritte der Arzneimittelforschung \/ Progr\u00e8s des recherches pharmaceutiques"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-0348-7150-1_6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T14:56:56Z","timestamp":1674485816000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-0348-7150-1_6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993]]},"ISBN":["9783034871525","9783034871501"],"references-count":141,"URL":"https:\/\/doi.org\/10.1007\/978-3-0348-7150-1_6","relation":{},"subject":[],"published":{"date-parts":[[1993]]}}}